These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 31371553)

  • 1. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment.
    Nishio H; Niba ETE; Saito T; Okamoto K; Takeshima Y; Awano H
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.
    Angilletta I; Ferrante R; Giansante R; Lombardi L; Babore A; Dell'Elice A; Alessandrelli E; Notarangelo S; Ranaudo M; Palmarini C; De Laurenzi V; Stuppia L; Rossi C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Advances in Spinal Muscular Atrophy.
    Bharucha-Goebel D; Kaufmann P
    Curr Neurol Neurosci Rep; 2017 Oct; 17(11):91. PubMed ID: 28983837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal Muscular Atrophy.
    Oskoui M; Servais L
    Continuum (Minneap Minn); 2023 Oct; 29(5):1564-1584. PubMed ID: 37851043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy in Ghanaian children confirmed by molecular genetic testing: a case series.
    Hammond CK; Oppong E; Ameyaw E; Dogbe JA
    Pan Afr Med J; 2023; 46():78. PubMed ID: 38282771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical practice guidelines for spinal muscular atrophy].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Pan J; Tan H; Zhou M; Liang D; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):263-268. PubMed ID: 32128742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.
    Schorling DC; Pechmann A; Kirschner J
    J Neuromuscul Dis; 2020; 7(1):1-13. PubMed ID: 31707373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape.
    Wood MJA; Talbot K; Bowerman M
    Hum Mol Genet; 2017 Oct; 26(R2):R151-R159. PubMed ID: 28977438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in spinal muscular atrophy therapeutics.
    Parente V; Corti S
    Ther Adv Neurol Disord; 2018; 11():1756285618754501. PubMed ID: 29434670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal Muscular Atrophy Treatments, Newborn Screening, and the Creation of a Neurogenetics Urgency.
    Butterfield RJ
    Semin Pediatr Neurol; 2021 Jul; 38():100899. PubMed ID: 34183144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report.
    Sansone VA; Walter MC; Attarian S; Delstanche S; Mercuri E; Lochmüller H; Neuwirth C; Vazquez-Costa JF; Kleinschnitz C; Hagenacker T
    J Neuromuscul Dis; 2020; 7(4):523-534. PubMed ID: 32538864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.